Article
Phenotypic correction of lipid storage and growth arrest in wolman disease fibroblasts by gene transfer of lysosomal acid lipase.
Human gene therapy - 10 Feb 2001
Tietge U J, Sun G, Czarnecki S, Yu Q, Lohse P, Du H, Grabowski G A, Glick J M, Rader D J
Abstract excerpt
Wolman disease is a lethal lysosomal storage disease due to deficiency of lysosomal acid lipase (LAL). Wolman disease is characterized by pronounced hepatic involvement while neurological symptoms are uncommon, making Wolman disease an attractive candidate for liver-directed gene therapy. This study was performed to test the effects of gene replacement in fibroblasts lacking LAL, using a recombinant adenovirus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
